Glycyrrhizin Inhibits R5 HIV Replication in Peripheral Blood Monocytes Treated with 1-Methyladenosine

R5 HIV replicated in freshly isolated human peripheral blood monocytes after treatment with 1-methyladenosine (fresh PBM/MA), an immunosuppressive compound isolated from tumorous ascites fluids, while viral replication was not demonstrated in untreated peripheral blood monocytes (fresh PBM). The R5 HIV replication in fresh PBM/MA was inhibited by glycyrrhizin (GL). Without any other stimulation, fresh PBM/MA produced CCL2 and IL-10, while these soluble factors were not released from fresh PBM. GL greatly inhibited the production of CCL2 and IL-10 in fresh PBM/MA. After treatment with CCL2 and/or IL-10, CCR5 mRNA expression in fresh PBM was markedly enhanced, while only a trace level of the mRNA expression was detected in these cells in the absence of CCL2 or IL-10. CCR5 mRNA expression in fresh PBM treated with CCL2 or IL-10 was clearly inhibited by GL. These results indicate that GL inhibits R5 HIV replication in fresh PBM/MA through the inhibiting CCR5 expression mediated by CCL2 or IL-10.

[1]  H. Doerr,et al.  Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus , 2003, The Lancet.

[2]  Makiko Kobayashi,et al.  Effect of Glycyrrhizin, an Active Component of Licorice Roots, on HIV Replication in Cultures of Peripheral Blood Mononuclear Cells from HIV-Seropositive Patients , 2003, Pathobiology.

[3]  P. Baré,et al.  Monocyte differentiation and HIV replication after prolonged culture of peripheral blood mononuclear cells from HIV-infected individuals. , 2001, Cellular immunology.

[4]  F. Belardelli,et al.  HIV-1 gp120 Stimulates the Production of β-Chemokines in Human Peripheral Blood Monocytes Through a CD4-Independent Mechanism1 , 2001, The Journal of Immunology.

[5]  D. Herndon,et al.  Glycyrrhizin restores the impaired IL-12 production in thermally injured mice. , 2001, Cytokine.

[6]  D. Gemsa,et al.  Increase of CCR1 and CCR5 expression and enhanced functional response to MIP‐1α during differentiation of human monocytes to macrophages , 2001, Journal of leukocyte biology.

[7]  A. Lazzarin,et al.  Divergent regulation of HIV‐1 replication in PBMC of infected individuals by CC chemokines: suppression by RANTES, MIP‐1α, and MCP‐3, and enhancement by MCP‐1 , 2000, Journal of leukocyte biology.

[8]  R. Pollard,et al.  Glycyrrhizin improves the resistance of MAIDS mice to opportunistic infection of Candida albicans through the modulation of MAIDS-associated type 2 T cell responses. , 2000, Clinical Immunology.

[9]  M. Loda,et al.  Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1 , 2000, Nature.

[10]  J. Weiss,et al.  HIV-1 Tat induces monocyte chemoattractant protein-1-mediated monocyte transmigration across a model of the human blood-brain barrier and up-regulates CCR5 expression on human monocytes. , 1999, Journal of immunology.

[11]  A. Bidani,et al.  Cytokine production by rabbit alveolar macrophages: differences between activated and suppressor cell phenotypes. , 1999, Immunology letters.

[12]  S. Matsushita,et al.  IL‐4 and a glucocorticoid up‐regulate CXCR4 expression on human CD4+ T lymphocytes and enhance HIV‐1 replication , 1998, Journal of leukocyte biology.

[13]  V. Torri,et al.  Elevated cerebrospinal fluid levels of monocyte chemotactic protein‐1 correlate with HIV‐1 encephalitis and local viral replication , 1998, AIDS.

[14]  J. Bousquet,et al.  Cutting Edge: IL-4 Induces Functional Cell-Surface Expression of CXCR4 on Human T Cells , 1998, The Journal of Immunology.

[15]  E. Major,et al.  Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Brouwer,et al.  glycyrrhizin as a potential treatment for chronic hepatitis C , 1998, Alimentary pharmacology & therapeutics.

[17]  C. Mackay,et al.  Interleukin 10 Increases CCR5 Expression and HIV Infection in Human Monocytes , 1998, The Journal of experimental medicine.

[18]  C. Blondin,et al.  Plasma levels of monocyte chemoattractant protein-1 but not those of macrophage inhibitory protein-1alpha and RANTES correlate with virus load in human immunodeficiency virus infection. , 1997, The Journal of infectious diseases.

[19]  G. Carr,et al.  The inhibition of synthesis of a beta-chemokine, monocyte chemotactic protein-1 (MCP-1) by progesterone. , 1997, Biochemical and biophysical research communications.

[20]  Makiko Kobayashi,et al.  Glycyrrhizin, an active component of licorice roots, reduces morbidity and mortality of mice infected with lethal doses of influenza virus , 1997, Antimicrobial agents and chemotherapy.

[21]  Hassan Mohammad Naif,et al.  The state of maturation of monocytes into macrophages determines the effects of IL-4 and IL-13 on HIV replication. , 1997, Journal of immunology.

[22]  A. Lazzarin,et al.  Selective elevation of monocyte chemotactic protein-1 in the cerebrospinal fluid of AIDS patients with cytomegalovirus encephalitis. , 1996, The Journal of infectious diseases.

[23]  Ying Sun,et al.  The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates , 1996, Cell.

[24]  Paul E. Kennedy,et al.  HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor , 1996, Science.

[25]  S. Arya,et al.  Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells , 1995, Science.

[26]  M. Frazier-Jessen,et al.  Estrogen modulation of JE/monocyte chemoattractant protein-1 mRNA expression in murine macrophages. , 1995, Journal of immunology.

[27]  N. Nagata,et al.  Effect of glycyrrhizin, cyclosporin A, and tumor necrosis factor α on infection of U‐937 and MRC‐5 cells by human cytomegalovirus , 1994, Journal of leukocyte biology.

[28]  T. Yokochi,et al.  Glycyrrhizin as a promoter of the late signal transduction for interleukin-2 production by splenic lymphocytes. , 1993, Immunology.

[29]  K. Matsushima,et al.  Dexamethasone inhibits the induction of monocyte chemotactic-activating factor production by IL-1 or tumor necrosis factor. , 1991, Journal of immunology.

[30]  T. Yoshida,et al.  Modulation by glycyrrhizin of the cell-surface expression of H-2 class I antigens on murine tumour cell lines and normal cell populations. , 1990, Immunology.

[31]  S. Matsushita,et al.  Preliminary evidence for inhibitory effect of glycyrrhizin on HIV replication in patients with AIDS. , 1989, Antiviral research.

[32]  K. Tada,et al.  Effects of glycyrrhizin (SNMC: Stronger Neo-Minophagen C) in hemophilia patients with HIV-1 infection. , 1989, The Tohoku journal of experimental medicine.

[33]  E. De Clercq,et al.  Mechanism of inhibitory effect of glycyrrhizin on replication of human immunodeficiency virus (HIV). , 1988, Antiviral research.

[34]  T. Suzutani,et al.  Enhancement of Interferon-γ Production in Glycyrrhizin-Treated Human Peripheral Lymphocytes in Response to Concanavalin A and to Surface Antigen of Hepatitis B Virus , 1986 .

[35]  R. Pompei,et al.  Glycyrrhizic acid inhibits virus growth and inactivates virus particles , 1979, Nature.

[36]  J. Ménard,et al.  Binding of glycyrrhetinic acid to kidney mineralocorticoid and glucocorticoid receptors. , 1975, Endocrinology.

[37]  A. Kumagai,et al.  Study on the corticoid-like action of glycyrrhizine and the mechanism of its action. , 1957, Endocrinologia japonica.

[38]  J. Farber,et al.  Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. , 1999, Annual review of immunology.

[39]  J. Bousquet,et al.  IL-4 induces functional cell-surface expression of CXCR4 on human T cells. , 1998, Journal of immunology.

[40]  S. Matsushita,et al.  Wang, J. et al. IL-4 and a glucocorticoid up-regulate CXCR4 expression on human CD4+ T lymphocytes and enhance HIV-1 replication. J. Leukoc. Biol. 64, 642−649 , 1998 .

[41]  Y. Seino,et al.  Effects of glycyrrhizin (SNMC: stronger Neo-Minophagen C) in hemophilia patients with HIV infection. , 1989, The Tohoku journal of experimental medicine.

[42]  S. Takano,et al.  Low molecular weight immunosuppressive factors found in elevated amounts in cancer ascitic fluids of mice. 2. 1-Methyladenosine isolated from cancer ascitic fluids enhances Listeria infection in mice. , 1986, Journal of immunopharmacology.